Aalto Scientists Experiment with Helium Plasma to Help Pave Way for Fusion Energy
 
  is expected to start operations using helium and hydrogen test plasmas before commencing experiments with deuterium and tritium, the more efficient fuel used by JET to break the world record for sustained fusion energy at the end of 2021. ITER鈥檚 goal is to prove the feasibility of fusion as a large-scale and carbon-free source of energy.
As part of , a research collaboration belonging to , scientists at Aalto University also participate in the JET studies. Mathias Groth, a researcher at Aalto, describes the work done in Otaniemi:
鈥漇cientists from the Fusion and Plasma Group at Aalto lead the investigations into the role of helium as the main fuel species in detaching plasma from the divertor target plates at the bottom of the experiment device. We employ comprehensive measurements and state-of-the-art computer simulations to isolate the role of hydrogenic molecules in the process of plasma detachment in hydrogenic plasmas by using helium plasmas. We also perform cutting-edge computer simulations to characterize heat-, particle-, and momentum transport in the cores of hydrogenic and helium plasma.鈥
Outside of Aalto, other EUROfusion researchers will study the behaviour of the plasmas as well as test the impact of helium on JET鈥檚 tungsten and beryllium wall to help ITER efficiently build up to full power operations once its construction finishes and operations begin in 2025.
More information
 
              Read more news
 
  H盲meenlinna Art Museum鈥檚 exhibition brings artworks to life through film
H盲meenlinna Art Museum will open a new exhibition Kehyskertomuksia: 24 fps / Reframing Cinema, produced in collaboration with the Aalto University Department of Film ELO. 
  New funding introduces health technology themes into FITech Network University's course offering
FITech Network University, a network of Finnish universities of technology coordinated by Aalto University, has been granted new funding that expands the network's course offering with themes related to health technology. 
  New macular degeneration treatment the first to halt disease鈥檚 progression
Aalto University researchers have uncovered a promising way to treat the dry form of the age- related macular degeneration (AMD) in the early diagnosis phase that could potentially stop its progression. The novel treatment approach aims to strengthen the protective mechanisms of affected cells using heat, explains Professor Ari Koskelainen. 
   
           
           
           
           
           
          